Retatrutide is a synthetic peptide being studied as a triple receptor agonist, effectively interacting with the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. Its research applications encompass the characterization of multi-receptor pharmacology, receptor-binding dynamics, downstream signaling pathways, and metabolic signaling mechanisms in experimental models.

For research purposes only. Not for human use.